COLLAGENEX PHARMACEUTICALS, INC. Restructuring and Exchange AgreementRestructuring and Exchange Agreement • December 21st, 2005 • Oaktree Capital Management LLC • Pharmaceutical preparations • Delaware
This Restructuring and Exchange Agreement (this “Agreement”) is dated as of December 15, 2005, by and among CollaGenex Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and the holders of outstanding Series D Cumulative Convertible Preferred Stock, $0.01 par value per share (the “Series D Preferred Stock”) of the Company set forth on the signature pages hereto (each a “Series D Holder” and collectively the “Series D Holders”).
